Lantern Pharma is trading 5.88% up at $1.44, primarily as broader positive biotech-sector sentiment lifts stocks.
- The move follows three consecutive declining sessions; XBI rose 2.07% during regular trading.
- Lantern Pharma is scheduled to present its Open-Medicine AI platform, development roadmap, and commercialization strategy at a 12:30 p.m. Eastern webinar on September 23, 2026.
- Available coverage does not establish the webinar as the direct catalyst.